Physician profile
Disha D Patel
NPI 1699919506
$12,507.77
in general payments reported to CMS, 2019-2025
71 companies · $2,907 in 2025
The $2,907 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,019 · 2020: $1,050 · 2021: $1,778 · 2022: $1,834 · 2023: $1,984 · 2024: $1,936 · 2025: $2,907.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,707 · Education: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,706.76 |
| Education | $119.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,200.79 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $1,896.10 | 2019-2025 | Repatha, Otezla, Otezla |
| Jazz Pharmaceuticals INC. | $729.50 | 2019-2025 | Xywav |
| Abbvie INC. | $570.92 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $487.06 | 2019-2024 | Belsomra, Steglatro, Verquvo |
| Lilly USA, LLC | $480.43 | 2022-2025 | Mounjaro, Zepbound, Omvoh |
| Janssen Biotech, INC. | $475.72 | 2023-2025 | Stelara, Tremfya |
| Harmony Biosciences LLC | $467.38 | 2021-2025 | Wakix |
| Avadel Cns Pharmaceuticals, LLC | $461.94 | 2023-2025 | Lumryz |
| Axsome Therapeutics, INC. | $392.95 | 2022-2025 | Sunosi, Auvelity |
| Glaxosmithkline, LLC. | $316.22 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $315.12 | 2019-2025 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $306.14 | 2019-2025 | Jardiance |
| Inspire Medical Systems, INC. | $245.57 | 2024-2025 | Inspire |
| Pfizer INC. | $231.13 | 2020-2025 |
Show all 71 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Disha Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.